The effectiveness of a benzydamine-based medication for the treatment of vulvovaginitis and bacterial vaginosis

Aim. To investigate the effectiveness of a modern benzydamine-based medication in the treatment of vulvovaginitis and bacterial vaginosis. Materials and methods. The study comprised 31 women with a mean age of32.34 years. The patients received outpatient medical care and were evaluated at three visits. All patients completed three visits. The diagnoses included candida vulvovaginitis, aerobic vulvovaginitis, and bacterial vaginosis. We analyzed the changes in the patients’ complaints reported at all three visits and microbiological findings of vaginal discharge. Results. The discomfort was reported by 23/31 (74.2%), 4/31 (12.9%), and 4/31 (12.9%) patients at visits 1, 2, and 3, respectively. The itching was reported by 19/31 (61.2%), 0, and 3patients at visits 1, 2, and 3, respectively. Sixteen (51.6%), 0, and 3 patients complained of genital burning at visits 1, 2, and 3, respectively. Conclusion. Our experience with the benzydamine-based medication Tantum Rosa has demonstrated its therapeutic effectiveness in the treatment of candidal and aerobic vulvovaginitis, and bacterial vaginosis. The effectiveness was confirmed by all generally accepted evaluation criteria, including objective examination, microbiological studies, and patient satisfaction.

candida vulvovaginitis, aerobic vulvovaginitis, bacterial vaginosis, benzydamine, Tantum Rosa